Xenazoic Acid

CHEMBL1909289 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
375.4 g/mol
LogP
4.8
Phase
4

Xenazoic acid is an aryl-aliphatic acid that has been investigated for its pharmacological properties, including potential anti-inflammatory and metabolic effects. It has been studied as a pharmaceutical intermediate and in research contexts related to peroxisome proliferator-activated receptor (PPAR) pharmacology. Limited clinical data are available on its therapeutic applications.

Moleküler Ağırlık

375,4000 g/mol

LogP

4,80

TPSA

75,60 Ų

Lipinski RO5

Geçer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCOC(Nc1ccc(C(=O)O)cc1)C(=O)c1ccc(-c2ccccc2)cc1

InChI

InChI=1S/C23H21NO4/c1-2-28-22(24-20-14-12-19(13-15-20)23(26)27)21(25)18-10-8-17(9-11-18)16-6-4-3-5-7-16/h3-15,22,24H,2H2,1H3,(H,26,27)

Molecular Formula

C23H21NO4

HBD / HBA

2 / 5

Döndürülebilir Bağlar

8

Ağır Atomlar

28

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

Xenazoic acid is an aryl-aliphatic acid that has been investigated for its pharmacological properties, including potential anti-inflammatory and metabolic effects. It has been studied as a pharmaceutical intermediate and in research contexts related to peroxisome proliferator-activated receptor (PPAR) pharmacology. Limited clinical data are available on its therapeutic applications.

Yes, Xenazoic Acid is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1909289. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 239062. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.